- About Us
- Nano-Social Network
- Nano Consulting
- My Account
November 3rd, 2004
Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, today announced its financial results for the third quarter ended September 30, 2004.
Total revenues for the third quarter of 2004 were $1.1 million compared to $1.7 million for the same period in 2003 and $1.1 million in the second quarter of 2004. Product revenues for the third quarter were $671,000 versus $752,000 for the same period in 2003 and were $477,000 in the second quarter of 2004.
|Related News Press|
Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016
Nanometrics Reports Second Quarter 2016 Financial Results July 26th, 2016